Unknown

Dataset Information

0

BA-12 Inhibits Angiogenesis via Glutathione Metabolism Activation.


ABSTRACT: There is a need for an efficient and low-cost leading compound discovery mode. However, drug development remains slow, expensive, and risky. Here, this manuscript proposes a leading compound discovery strategy based on a combination of traditional Chinese medicine (TCM) formulae and pharmacochemistry, using a ligustrazine-betulinic acid derivative (BA-12) in the treatment of angiogenesis as an example. Blocking angiogenesis to inhibit the growth and metastasis of solid tumors is currently one recognized therapy for cancer in the clinic. Firstly, based on a traditional Prunella vulgaris plaster, BA-12 was synthesized according to our previous study, as it exhibited better antitumor activities than other derivatives on human bladder carcinoma cells (T24); it was then uploaded for target prediction. Secondly, the efficacy and biotoxicity of BA-12 on angiogenesis were evaluated using human umbilical vein endothelial cells (HUVECs), a quail chick chorioallantoic membrane, and Caenorhabditis elegans. According to the prediction results, the main mechanisms of BA-12 were metabolic pathways. Thus, multiple metabolomics approaches were applied to reveal the mechanisms of BA-12. Finally, the predictive mechanisms of BA-12 on glutathione metabolism and glycerophospholipid metabolism activation were validated using targeted metabolomics and pharmacological assays. This strategy may provide a reference for highly efficient drug discovery, with the aim of sharing TCM wisdom for unmet clinical needs.

SUBMITTER: Cui H 

PROVIDER: S-EPMC6720627 | biostudies-literature | 2019 Aug

REPOSITORIES: biostudies-literature

altmetric image

Publications

BA-12 Inhibits Angiogenesis via Glutathione Metabolism Activation.

Cui Herong H   Guo Wenbo W   Zhang Beibei B   Li Guoping G   Li Tong T   Yuan Yanyan Y   Zhang Na N   Yang Yuwei Y   Feng Wuwen W   Chu Fuhao F   Wang Shenglan S   Xu Bing B   Wang Penglong P   Lei Haimin H  

International journal of molecular sciences 20190820 16


There is a need for an efficient and low-cost leading compound discovery mode. However, drug development remains slow, expensive, and risky. Here, this manuscript proposes a leading compound discovery strategy based on a combination of traditional Chinese medicine (TCM) formulae and pharmacochemistry, using a ligustrazine-betulinic acid derivative (BA-12) in the treatment of angiogenesis as an example. Blocking angiogenesis to inhibit the growth and metastasis of solid tumors is currently one re  ...[more]

Similar Datasets

| S-EPMC2990696 | biostudies-literature
2023-11-22 | GSE211128 | GEO
| S-EPMC10799372 | biostudies-literature
| S-EPMC4323001 | biostudies-literature
| S-EPMC1502086 | biostudies-literature
| S-EPMC7211987 | biostudies-literature
| S-EPMC9095711 | biostudies-literature
| S-EPMC9293154 | biostudies-literature
| S-EPMC2901489 | biostudies-literature
| S-EPMC10716292 | biostudies-literature